DM: Diabetes mellitus DM1: Diabetes mellitus type 1 – F/M: Female/Male – No.: Number – NOP: number of patients
References:
1. Naumowicz M, Modzelewski S, Macko A, Łuniewski B, Baran A, Flisiak I. A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation. International Journal of Molecular Sciences. 2024;25(6):3482.2. Erfurt-Berge C, Heusinger V, Reinboldt-Jockenhöfer F, Dissemond J, Renner R. Comorbidity and therapeutic approaches in patients with necrobiosis lipoidica. Dermatology. 2022;238(1):148-55.3. Papara C, De Luca DA, Bieber K, Vorobyev A, Ludwig RJ. Morphea: the 2023 update. Frontiers in medicine. 2023;10:1108623.4. Acebo E, Gardeazábal J, Marcellán M, Lasa O, Burgos JJ, Díaz-Pérez JL. Necrobiosis lipoidica over appendectomy scar in a patient with morphea of the breast. Actas Dermo-sifiliograficas. 2006;97(1):52-5.5. Severson KJ, Patel MH, Brumfiel CM, Breen I, Butterfield RJ, Nelson SA, et al. Comorbidities and diabetic complications in patients with necrobiosis lipoidica. Journal of the American Academy of Dermatology. 2022;86(4):891-4.6. Hashemi DA, Brown-Joel ZO, Tkachenko E, Nelson CA, Noe MH, Imadojemu S, et al. Clinical features and comorbidities of patients with necrobiosis lipoidica with or without diabetes. JAMA dermatology. 2019;155(4):455-9.7. Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A, et al. German guidelines for the diagnosis and therapy of localized scleroderma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2016;14(2):199-216.8. Jockenhöfer F, Kröger K, Klode J, Renner R, Erfurt‐Berge C, Dissemond J. Cofactors and comorbidities of necrobiosis lipoidica: analysis of the German DRG data from 2012. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2016;14(3):277-84.9. Erfurt-Berge C, Seitz A-T, Rehse C, Wollina U, Schwede K, Renner R. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. European Journal of Dermatology. 2012;22(6):770-5.10. Marcoval J, Gómez-Armayones S, Valentí-Medina F, Bonfill-Ortí M, Martínez-Molina L. Necrobiosis lipoidica: a descriptive study of 35 cases. Actas Dermo-Sifiliográficas (English Edition). 2015;106(5):402-7.11. MULLER SA, Winkelmann R. Necrobiosis lipoidica diabeticorum: a clinical and pathological investigation of 171 cases. Archives of Dermatology. 1966;93(3):272-81.12. Ionescu C, Petca A, Dumitrașcu MC, Petca R-C, Ionescu AI, Șandru F. The Intersection of Dermatological Dilemmas and Endocrinological Complexities: Understanding Necrobiosis Lipoidica—A Comprehensive Review. Biomedicines. 2024;12(2):337.13. Heite H-J, Scharwenka H. Erythema elevatum diutinum, Granuloma anulare, Necrobiosis lipoidica und Granulomatosis disciformis Gottron-Miescher: Eine vergleichende häufigkeitsanalytische Studie. Archiv für klinische und experimentelle Dermatologie. 1959;208(3):260-90.14. O’toole E, Kennedy U, Nolan J, Young M, Rogers S, Barnes L. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. British Journal of Dermatology. 1999;140(2):283-6.15. Erfurt-Berge C, Dissemond J, Schwede K, Seitz A-T, Al Ghazal P, Wollina U, et al. Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study. European Journal of Dermatology. 2015;25:595-601.16. Hammer E, Lilienthal E, Hofer SE, Schulz S, Bollow E, Holl R, et al. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus. Diabetic Medicine. 2017;34(1):86-92.